No supplement treats perimenopause itself, but a short list has credible evidence for specific symptoms and a much longer list does not. The transition is driven by fluctuating rather than simply low estradiol, alongside falling luteal progesterone (STRAW+10, Harlow et al., 2012), which is why capsules promising to "balance hormones" rarely do what the label implies. What supplements can do is correct a measured deficiency, protect bone and muscle through a decade of accelerated loss, and in a few cases modestly reduce hot flashes, poor sleep or low mood. This guide sorts the options into three evidence tiers, gives the forms and ranges used in trials, flags the interactions to clear first, and names what to leave on the shelf.
Free interactive tool
Supplement shelf check
Tick what is on your shelf to see where each item sits in the three evidence tiers, and which interactions to clear first.
In this article
- Food, sleep and resistance training set the ceiling on what any supplement adds
- A three-tier evidence framework you can apply to any product you are sold
- Tier 1: vitamin D, magnesium, omega-3, creatine, and the labs behind iron and B12
- Tier 2: soy isoflavones, black cohosh, ashwagandha and named probiotic strains
- Tier 3: the heavily marketed ingredients with thin, negative or unsafe evidence
- Cortisol and "adrenal support" formulas, and what lab tests found inside them
- A symptom-by-symptom guide, including brain fog
- Forms, studied ranges, interactions and third-party quality checks
- How to check any product before you buy it, without a brand ranking
- A sequencing approach that avoids buying nine bottles at once
- Red flags that call for a clinician before any supplement
Food, sleep and training set the ceiling
Supplements are correction tools, not substitutes. A woman eating 60 grams of protein a day and sleeping six broken hours will not out-supplement either problem. The Institute for Functional Medicine places nutrition and lifestyle at the base of the therapeutic order, with targeted nutrients layered on afterwards (IFM). Protein at every meal defends lean mass, fiber steadies post-meal glucose and supports estrogen clearance through the gut, and regular meal timing blunts afternoon crashes. Where weight or energy has shifted, those mechanisms usually explain more than any nutrient gap, as the pieces on perimenopause weight gain and perimenopause fatigue set out.
Set expectations accordingly. In the better trials, effective non-hormonal options reduce hot flash frequency by a modest margin over placebo, not to zero (The Menopause Society). A supplement promising transformation is making a bigger claim than its data.
Prescription non-hormonal options have also widened. Elinzanetant (Lynkuet) was approved on 24 October 2025 as a second non-hormonal option for hot flashes, acting on the NK1 and NK3 receptors. Fezolinetant, the earlier drug in that class, gained a boxed warning for rare but serious liver injury in December 2024. Both are prescribing decisions for your own clinician.
How to read the evidence: three tiers
This is the filter we use when a patient arrives with a photograph of a shelf and a question about which of it is worth keeping.
| Tier | What the evidence looks like | Reasonable expectation | Examples |
|---|---|---|---|
| Tier 1 | Replicated trials for a defined outcome, or correction of a deficiency confirmed on labs | A measurable effect on the outcome studied | Vitamin D, magnesium, omega-3, creatine, iron or B12 when labs justify them |
| Tier 2 | Trials exist but are mixed, effects are small, or benefit sits in a subgroup | Worth a defined 8 to 12 week trial for one symptom | Soy isoflavones, black cohosh, ashwagandha, melatonin, named probiotic strains |
| Tier 3 | Mechanism, tradition or animal data, or trials that failed to beat placebo | Low probability of benefit, and some real safety questions | Wild yam cream, dong quai, evening primrose oil, adrenal glandulars, blends |
Two rules follow. Tier belongs to the outcome, not the ingredient: magnesium has good evidence for repletion, fair evidence for sleep and none for "balancing estrogen". And tier is not safety: some Tier 3 products are merely wasteful, a few are risky.
Tier 1: the short list
Vitamin D
Vitamin D matters in this decade mainly for bone, because loss accelerates in late perimenopause and the first postmenopausal years (NIH ODS). The Endocrine Society's 2024 guideline suggests against routine 25-hydroxy vitamin D testing without an established medical reason (Demay et al., 2024). Ask your clinician whether a test fits your situation. D3 raises serum levels more efficiently than D2 and absorbs better with fat. Very high-dose regimens have shown no added benefit and, in some trials, harm.
The Institute of Medicine set the vitamin D RDA at 600 IU a day through age 70 (Ross et al., 2011). The RDA is the daily intake that covers at least 97.5% of people. The upper limit for adults is 4,000 IU a day. A blood level of 20 ng/mL meets the needs of nearly everyone. Levels above 30 ng/mL were not consistently linked to more benefit, and above 50 ng/mL should raise concern about possible harm. Your clinician reads your own result against these markers.
Magnesium
Low intakes are common and status is poorly captured on standard serum testing (NIH ODS). In perimenopause it is used for sleep quality, cramps and constipation. Form decides purpose: glycinate and threonate are better tolerated for sleep and repletion, citrate is mildly laxative, oxide is poorly absorbed. ODS lists a 350 mg daily upper limit for supplemental magnesium, separate from food, and it accumulates in reduced kidney function.
Omega-3 (EPA and DHA)
Marine omega-3s have solid evidence for lowering triglycerides and mixed evidence for mood at higher EPA ratios; evidence for hot flashes is weak (NIH ODS). Read combined EPA plus DHA per serving rather than total fish oil, which is often three times larger. Triglyceride-form products absorb better than ethyl esters, and two portions of oily fish weekly reaches similar territory.
Creatine monohydrate
Creatine is the most under-discussed Tier 1 option for women in this age band. Trials pair it with resistance training and report gains in strength and lean mass, with the studied range around 3 to 5 grams daily. It is not a hormone and does nothing to estradiol; it supports the training that protects the muscle and bone actually at risk. Monohydrate is the studied form, and the early water-weight shift is intramuscular rather than fat.
Iron, B12 and calcium: test, do not guess
Heavy or unpredictable bleeding defines much of the transition, and iron deficiency is a frequent, treatable cause of fatigue blamed on hormones. Iron is supplemented against ferritin and a blood count, never symptoms alone, because unnecessary iron causes harm (NIH ODS). B12 deserves the same discipline where metformin, acid-suppressing medication or low animal-food intake are in play (NIH ODS). Calcium is best reached through food, since supplemental calcium beyond the recommended intake adds no skeletal benefit (NIH ODS). All three belong in the panel described in our guide to hormone testing for women.
For calcium, the RDA is 1,000 mg a day for women up to 50 and 1,200 mg from 51 (Ross et al., 2011). That total counts food and supplements together. The upper limits are 2,500 mg a day up to 50 and 2,000 mg from 51. The main food sources are dairy, fortified foods, legumes, nuts and selected vegetables, so a supplement only needs to cover the gap.
Tier 2: worth a defined trial for one symptom
Soy isoflavones and S-equol
Isoflavones are the best-studied plant option for vasomotor symptoms, with meta-analyses reporting a modest reduction in hot flash frequency against placebo over several weeks (NCCIH). The wrinkle is S-equol: only some women carry gut bacteria that convert daidzein into equol, the more active metabolite, which may explain why trials split. Whole soy foods come before concentrated extracts.
Red clover extracts also supply isoflavones, and their results are split. A 2013 Cochrane review pooled five trials of one such extract and found no clear drop in hot flashes (Lethaby et al., 2013). A 2026 analysis of nine trials found a small-to-moderate drop in frequency (Jiang and Wu, 2026). Mixed trials like these are Tier 2 by definition, so the same 8 to 12 week rule applies.
Black cohosh
Black cohosh has been trialed extensively with genuinely mixed results, and NCCIH concludes the evidence does not clearly support benefit while noting rare reports of liver injury (NCCIH). It is not an estrogen. If trialed, use a single standardized product rather than one ingredient buried in a blend, for a defined period, stopping for jaundice, dark urine or upper abdominal pain.
Ashwagandha
Small randomized trials of standardized extracts report improvements in perceived stress and sleep quality over 8 to 12 weeks, with studied amounts clustered around 300 to 600 mg daily. The trials are small and frequently industry-funded, which keeps it in Tier 2. It has immune-stimulating properties and case reports of thyroid function change, so anyone with Hashimoto's should raise it first; see our autoimmune care page.
Probiotics, strain by strain
Probiotic evidence is strain-specific and does not transfer between products. Named strains have trial support for bloating and regularity, which matters here because the gut participates in estrogen clearance. A label reading only "Lactobacillus blend" matches no trial. Our digestive and gut health page covers how gut symptoms are worked up alongside hormonal ones.
Tier 3: heavily marketed, thinly evidenced
Each of these appears constantly in perimenopause stacks, and each is here for a specific reason rather than a general suspicion of botanicals.
- Wild yam cream. Diosgenin becomes progesterone in a laboratory, not in the human body. It does not raise progesterone.
- Over-the-counter progesterone creams. Potency and absorption vary widely and unsupervised use has endometrial consequences. This is a prescription conversation.
- Oral DHEA. A hormone precursor sold as a supplement, converting to estrogen and testosterone at variable rates. The Endocrine Society treats androgen therapy as supervised prescribing.
- Dong quai. No benefit for hot flashes in controlled trials, plus anticoagulant and photosensitizing effects.
- Evening primrose oil. Repeatedly trialed for hot flashes and breast tenderness with largely negative results.
- Flaxseed for hot flashes. A daily flaxseed bar with 410 mg of lignans did no better than placebo over 6 weeks (Pruthi et al., 2012). That trial enrolled 188 postmenopausal women. As a food, flax still adds fiber.
- Maca. Small, low-quality libido trials; harmless as food, unjustified at extract prices.
- DIM and I3C. Sold on laboratory data. They shift measured estrogen metabolites without demonstrated symptom benefit, which makes them easy to sell alongside a test result.
- Adrenal glandulars and "adrenal fatigue" formulas. Adrenal fatigue is a popular label; the measurable pattern behind it is HPA-axis dysregulation, which is what testing and treatment address. It is assessed through cortisol rhythm and history rather than treated with dried animal tissue.
- Licorice root. Glycyrrhizin raises blood pressure and lowers potassium, yet appears unflagged in many "hormone support" blends.
- High-dose vitamin E. Marginal effect on hot flashes, bleeding risk at dose.
Cortisol and "adrenal support" formulas
These products are marketed for real complaints: poor sleep, low energy, feeling on edge. Adrenal fatigue is a popular label for that picture, and clinicians describe the pattern as HPA-axis dysregulation. HPA means hypothalamic-pituitary-adrenal, the brain-to-adrenal loop that sets your cortisol rhythm. In a study that followed women through the transition, urine cortisol rose as they entered its late stage (Woods et al., 2006). Women with a clear rise had more severe hot flashes and night sweats. Their sleep, mood and stress levels did not differ.
What is inside the bottle matters more than the name. A 2018 lab study tested 12 "adrenal support" products bought over the counter (Akturk et al., 2018). Every one contained thyroid hormone (T3), and most contained at least one steroid hormone. Three contained budesonide, a synthetic steroid medicine. It is one more reason adrenal glandulars sit in Tier 3.
Of the herbs in this guide, ashwagandha is the one with cortisol trials, and it stays in Tier 2. A 2025 pooled analysis of 7 trials found lower cortisol levels than placebo (Albalawi, 2025). Stress questionnaire scores did not change clearly in that analysis, so a lower lab value is not the same as feeling calmer. One 8-week trial in 100 perimenopausal women, at 300 mg twice daily, reported lower menopause symptom scores (Gopal et al., 2021). Case reports also link ashwagandha to liver injury, with jaundice and itching 2 to 12 weeks after starting (Björnsson et al., 2020).
The more useful step is to assess the rhythm itself, read with your sleep, stress and cycle history. Our guide to hormone testing for women explains how.
Supplements by symptom: a decision guide
You probably arrived here with a symptom, not an ingredient. This table pulls the tiers above into one view, with the checks to run first. Each tier applies to that symptom only, because tier belongs to the outcome.
| Symptom | Check first | Options and tier for this symptom | Note |
|---|---|---|---|
| Hot flashes and night sweats | How much they disrupt your sleep and work | Soy isoflavones (Tier 2), black cohosh (Tier 2), red clover (Tier 2) | Hormone therapy is the most effective option for moderate to severe symptoms in suitable candidates |
| Poor sleep | Sleep history, including sleep apnea | Magnesium (fair evidence for sleep), melatonin (Tier 2), ashwagandha (Tier 2) | Glycinate and threonate are better tolerated for sleep |
| Stress, low mood, anxiety | Thyroid panel and sleep history; thoughts of self-harm need help now (see red flags below) | Omega-3 with higher EPA (mixed evidence), ashwagandha (Tier 2) | Our piece on hormone imbalance and anxiety covers the workup |
| Brain fog | Thyroid, ferritin and sleep | Creatine (early memory data, not Tier 1 for this outcome) | See the brain fog note below |
| Fatigue | Ferritin and blood count, B12, thyroid, glucose | Iron or B12 only when labs show a gap (Tier 1) | Unneeded iron causes harm |
| Bone protection | Your calcium and vitamin D intake from food. A vitamin D test only with a clear medical reason | Vitamin D when low (Tier 1), calcium mainly from food | Resistance training also protects bone |
| Muscle and strength | Protein at every meal | Creatine monohydrate with resistance training (Tier 1) | 3 to 5 g daily in trials |
| Bloating and irregularity | A gut workup if it persists | Named probiotic strains (Tier 2) | A label must name the strain, not just a blend |
Brain fog
For brain fog, the supplement evidence is limited, so the mimic checks come first. A 2023 analysis of 8 creatine trials found a small overall memory gain, clearest in adults 66 to 76 (Prokopidis et al., 2023). People aged 11 to 31 showed no clear change, and midlife women were not studied as a group. A published letter has also questioned the analysis for double-counting (Eckert and Pascher, 2023). For memory, that puts creatine in Tier 2 territory, even though it is Tier 1 for strength. Our perimenopause brain fog guide covers the wider workup.
Forms and studied ranges: how to read a label
Labels rarely match the trials they imply. These describe what research used, not what you should take; the right amount is a conversation with a clinician who knows your labs and medication list.
| Supplement | Form used in studies | Range seen in studies | Outcome studied | Label note |
|---|---|---|---|---|
| Vitamin D | D3 (cholecalciferol) | Titrated to a low 25-OH-D result | Bone density, deficiency correction | Take with fat; retest, do not escalate blindly |
| Magnesium | Glycinate, threonate, citrate | Supplemental limit 350 mg daily (ODS) | Sleep quality, cramps, repletion | Oxide poorly absorbed; citrate loosens stools |
| Omega-3 | Triglyceride-form EPA/DHA | 1 to 2 g combined EPA plus DHA | Triglycerides, mood support | Read EPA+DHA per serving, not total oil |
| Creatine | Monohydrate | 3 to 5 g daily with resistance training | Strength, lean mass | Premium variants add cost, not data |
| Soy isoflavones | Soy foods or standardized extract | 50 to 80 mg isoflavones daily | Hot flash frequency | Allow 6 to 12 weeks; responders may be equol producers |
| Black cohosh | Standardized root extract | 20 to 80 mg extract daily | Vasomotor symptoms (mixed) | Single-ingredient only; stop for liver symptoms |
| Ashwagandha | Standardized root extract | 300 to 600 mg daily | Perceived stress, sleep quality | Caution in autoimmune thyroid disease |
| Iron | Ferrous bisglycinate or sulfate | Set against ferritin and blood count | Iron-deficiency fatigue | Keep 4 hours from levothyroxine |
How to check any product before you buy it
Searching a brand name with "perimenopause" is a sensible instinct. We do not rate brands, but you can run the same checks we use on any bottle.
- Look for a quality mark. A USP Verified mark means testing confirmed the listed ingredients in the declared amounts (USP). It also covers harmful levels of contaminants such as heavy metals, FDA manufacturing practices, and whether the tablet breaks down. It checks quality, not whether the ingredient helps your symptom.
- Match the dose to the studied dose. Compare the amount per serving with the ranges table above. For omega-3, add EPA and DHA rather than reading total fish oil.
- Check the form. Look for D3, glycinate or citrate magnesium rather than oxide, creatine monohydrate, and a standardized extract for any herb.
- Find every amount. FDA rules do not require each ingredient inside a "proprietary blend" to show its own amount (FDA). If you cannot see the amount, you cannot match it to a trial.
- Read the claim wording. A claim about how a product supports the body must carry a note that FDA has not evaluated it (FDA). Match the claim to a trial in this guide instead.
- Bring the label, not the brand name. A photo of the Supplement Facts panel lets your clinician check dose, form and interactions together.
Interactions and quality checks to clear first
Supplements are not reviewed for safety or efficacy before sale; the FDA acts after products reach the market (FDA). Choose third-party-verified products carrying USP or NSF marks, and bring the whole bottle list to every appointment, because interactions are where the real harm sits.
- St John's wort induces CYP3A4 and undermines hormonal contraception, some antidepressants, anticoagulants and tamoxifen.
- Black cohosh carries rare hepatotoxicity reports; stop for jaundice, dark urine or right upper abdominal pain.
- Fish oil can prolong bleeding time and is usually paused before surgery.
- Calcium and iron block levothyroxine absorption and need about four hours of separation from it.
- Magnesium accumulates in reduced kidney function and blocks some antibiotics taken together.
- Licorice raises blood pressure and depletes potassium, a poor pairing with diuretics.
- Isoflavone extracts need an oncology conversation where there is a personal history of hormone-receptor-positive breast cancer.
Interactive tool
Supplement shelf check
Tick what is on your shelf to see where each item sits in the three evidence tiers, and which interactions to clear first.
What to skip regardless of the ingredient list
- Proprietary blends listing one total milligram figure for twelve ingredients, so nothing can be matched to a trial dose.
- Products sold straight off a free online "hormone quiz" that diagnoses you and sells the answer.
- "Detox" and "estrogen reset" kits, which promise more than the physiology supports.
- Nine bottles started in one week, which makes benefit and side effects equally untraceable.
- Anything positioned as an alternative to checking thyroid function, ferritin, glucose or sleep apnea.
A sequencing approach that avoids waste
The women who get most from supplements take the fewest, in a deliberate order.
- Rule out mimics. Thyroid panel with antibodies, ferritin and full blood count, fasting glucose and insulin, sleep history.
- Interpret hormones with timing. Serum estradiol and progesterone are read against cycle phase, and urinary panels such as DUTCH describe metabolite output rather than diagnosing the transition.
- Correct measured deficiencies before anything botanical.
- Change one thing at a time. One Tier 2 trial, one target symptom, 8 to 12 weeks, one daily score.
- Stop what did nothing. A supplement that has not moved its target symptom in three months is a subscription, not a treatment.
That order also keeps the hormone therapy conversation open. These are not competing philosophies: The Menopause Society treats hormone therapy as the most effective option for moderate to severe vasomotor symptoms in appropriate candidates, with non-hormonal options for women who cannot or prefer not to use it. Our perimenopause and menopause care page covers how both sit in one plan, and the complete functional medicine guide to perimenopause gives the wider context. The functional medicine process page explains how a workup at Interlinked Wellness is structured for women in Texas, Idaho, Colorado, Utah, and Arizona.
On 10 November 2025 the FDA removed the boxed warnings about cardiovascular disease, breast cancer and probable dementia from menopausal hormone therapy products, and the first six relabeled products were approved on 12 February 2026. The boxed warning about endometrial cancer stays on systemic estrogen-alone products. The Menopause Society's position statement remains the 2022 edition as of September 2026, and the Society supported removing the warning from low-dose vaginal estrogen. Where you land on it belongs with your prescribing clinician.
When to see a clinician before trying supplements
Some changes need a visit before any new bottle. Mayo Clinic lists these bleeding changes as reasons to see your clinician:
- Bleeding that is very heavy or lasts longer than seven days.
- Bleeding between periods, or periods that usually come less than 21 days apart.
- Any bleeding after 12 months without a period.
Also book a visit if any symptom bothers you. If you feel depressed, see a clinician soon. If you think you may hurt yourself, call 911 now. For thoughts of suicide, you can also call or text 988 to reach the Suicide & Crisis Lifeline (Mayo Clinic). If you already take black cohosh or ashwagandha, stop and call for yellow skin or eyes, dark urine, itching or upper abdominal pain.
FAQ
Do any supplements actually help hot flashes?
Soy isoflavones carry the most consistent signal, with meta-analyses reporting a modest reduction in frequency over placebo after six to twelve weeks. Black cohosh results are mixed and NCCIH concludes the evidence does not clearly support it. Neither approaches the effect size of hormone therapy in suitable candidates, so a supplement trial should not delay a treatment conversation when symptoms are disrupting sleep and work.
Is black cohosh safe?
Short-term use appears well tolerated for most people, but NCCIH notes rare reports of liver injury, some serious, with causality hard to establish because many products are multi-ingredient blends. The safer approach is a single standardized product from a third-party-verified brand, a defined trial period, awareness of liver warning signs, and a prior conversation with your clinician if you have a liver condition.
Can supplements replace hormone therapy?
No, and treating it as a contest leads to poor decisions. Hormone therapy remains the most effective treatment for moderate to severe vasomotor symptoms in appropriate candidates according to The Menopause Society, with risks that depend on age, time since the final period, route and personal history. Supplements address different targets: deficiency correction, bone and muscle support, modest symptom modulation.
Is soy safe if breast cancer runs in my family?
Dietary soy foods are viewed differently from concentrated isoflavone supplements. Observational data in populations with high habitual soy intake have not shown increased breast cancer risk, and some show the opposite association, though association is not causation. Extracts have much thinner safety data, and anyone with a personal history of hormone-receptor-positive breast cancer should decide about them with their oncology team.
How long should I trial something before deciding it works?
Eight to twelve weeks for most Tier 2 botanicals, because isoflavone and black cohosh trials need roughly that long to separate from placebo. Deficiency correction differs: iron and B12 repletion often show over four to eight weeks, with a repeat lab to confirm. Track one target symptom daily, because memory invents improvement that did not happen.
Do hormone balancing supplements work for perimenopause?
Rarely in the way the label implies, because the transition is driven by fluctuating rather than simply low estradiol. What supplements can do is correct a measured deficiency, support bone and muscle, and in a few cases modestly ease one symptom.
What supplements help with perimenopause brain fog?
Start with the mimic checks: thyroid, ferritin and sleep. Pooled creatine trials found a small memory gain, clearest in adults aged 66 to 76. Midlife women were not studied as a group, so treat creatine as a defined trial.
Do adrenal support or cortisol supplements help in perimenopause?
Adrenal fatigue is a popular label, and clinicians describe the pattern as HPA-axis dysregulation. Adrenal glandulars sit in Tier 3, and a 2018 lab study found thyroid hormone in all 12 "adrenal support" products it tested. Ashwagandha stays in Tier 2.
How can I tell if a perimenopause supplement brand is any good?
We do not rate brands, but you can check any product. Look for a USP or NSF mark, a dose and form that match the studied ranges, and no blend hiding amounts. A USP mark confirms what is in the bottle, not whether it helps your symptom.
How much vitamin D and calcium do I need in perimenopause?
The vitamin D RDA is 600 IU a day through age 70, with an upper limit of 4,000 IU. For calcium it is 1,000 mg a day up to age 50 and 1,200 mg from 51, counting food.
Can I take supplements while on hormone therapy?
Clear the full list with your prescriber first, because some supplements interact with estrogen. The FDA label for an estradiol gel warns that St John's wort may lower blood estrogen levels (FDA). That can weaken the effect or change bleeding.
References
- Harlow SD, et al. The Journal of Clinical Endocrinology and Metabolism. 2012. https://pubmed.ncbi.nlm.nih.gov/22344196/
- NIH Office of Dietary Supplements. National Institutes of Health. 2025. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
- NIH Office of Dietary Supplements. National Institutes of Health. 2026. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
- NIH Office of Dietary Supplements. National Institutes of Health. 2025. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
- NIH Office of Dietary Supplements. National Institutes of Health. 2025. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/
- NIH Office of Dietary Supplements. National Institutes of Health. 2025. https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/
- NIH Office of Dietary Supplements. National Institutes of Health. 2026. https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/
- National Center for Complementary and Integrative Health. National Institutes of Health. 2017. https://www.nccih.nih.gov/health/menopausal-symptoms-in-depth
- National Center for Complementary and Integrative Health. National Institutes of Health. 2024. https://www.nccih.nih.gov/health/black-cohosh
- Endocrine Society. Endocrine Society. 2022. https://www.endocrine.org/clinical-practice-guidelines
- U.S. Food and Drug Administration. U.S. Food and Drug Administration. 2024. https://www.fda.gov/food/dietary-supplements
- US Food and Drug Administration. US Food and Drug Administration. 2025. https://www.fda.gov/news-events/press-announcements/hhs-advances-womens-health-removes-misleading-fda-warnings-hormone-replacement-therapy
- Ross AC, et al. The Journal of Clinical Endocrinology and Metabolism. 2011. https://pubmed.ncbi.nlm.nih.gov/21118827/
- Lethaby A, et al. Cochrane Database of Systematic Reviews. 2013. https://pubmed.ncbi.nlm.nih.gov/24323914/
- Jiang W, Wu K. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2026. https://pubmed.ncbi.nlm.nih.gov/42269521/
- Pruthi S, et al. Menopause. 2012. https://pubmed.ncbi.nlm.nih.gov/21900849/
- Woods NF, et al. Menopause. 2006. https://pubmed.ncbi.nlm.nih.gov/16645535/
- Akturk HK, et al. Mayo Clinic Proceedings. 2018. https://pubmed.ncbi.nlm.nih.gov/29502560/
- Albalawi AA. Nutrition and Health. 2025. https://pubmed.ncbi.nlm.nih.gov/40746175/
- Gopal S, et al. Journal of Obstetrics and Gynaecology Research. 2021. https://pubmed.ncbi.nlm.nih.gov/34553463/
- Björnsson HK, et al. Liver International. 2020. https://pubmed.ncbi.nlm.nih.gov/31991029/
- Prokopidis K, et al. Nutrition Reviews. 2023. https://pubmed.ncbi.nlm.nih.gov/35984306/
- Eckert I, Pascher E. Nutrition Reviews. 2023. https://pubmed.ncbi.nlm.nih.gov/36644917/
- United States Pharmacopeia. Why USP Verified Matters. 2026. https://www.quality-supplements.org/why-usp-verified-matters
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. 2026. https://www.fda.gov/food/information-consumers-using-dietary-supplements/questions-and-answers-dietary-supplements
- U.S. Food and Drug Administration. Estradiol gel prescribing information. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021166s019lbl.pdf
- Mayo Clinic. Perimenopause: symptoms and causes. 2026. https://www.mayoclinic.org/diseases-conditions/perimenopause/symptoms-causes/syc-20354666
- Mayo Clinic. Depression (major depressive disorder): symptoms and causes. 2026. https://www.mayoclinic.org/diseases-conditions/depression/symptoms-causes/syc-20356007
- Demay MB, et al. The Journal of Clinical Endocrinology and Metabolism. 2024. https://pubmed.ncbi.nlm.nih.gov/38828931/
About the author
Medical disclaimer. The information on this page is provided for general education and is not individualized medical advice. At Interlinked Wellness, Anna Evans, MSN, APRN, FNP-C, provides personalized care based on your health history, symptoms, concerns, and goals. An individual consultation allows Anna to evaluate your specific situation and recommend an appropriate approach to care. Reading this page alone does not establish a patient-provider relationship. If you are experiencing a medical emergency, call 911 or your local emergency services.
Join Anna on a virtual wellness journey and unlock your full potential.






















